Brief: Meiragtx Announces $30 mln Strategic Investment From Sanofi Company

MeiraGTx Holdings

30/10/2023 11:38

Oct 30 (Reuters) - MeiraGTx Holdings PLC  MGTX.O :
    * MEIRAGTX ANNOUNCES $30 MILLION STRATEGIC INVESTMENT FROM
SANOFI;
COMPANY PURSUING MULTIPLE ADDITIONAL STRATEGIC OPPORTUNITIES
    * MEIRAGTX HOLDINGS PLC - SANOFI TO PURCHASE $30 MILLION OF
ORDINARY SHARES OF COMPANY AT A PRICE OF $7.50 PER SHARE
    * MEIRAGTX - ENGAGED EVERCORE, WACHTELL LIPTON TO EXECUTE
ADDITIONAL POTENTIAL STRATEGIC TRANSACTIONS
    * MEIRAGTX HOLDINGS PLC - APPROACHED BY MULTIPLE PARTIES
WITH
STRATEGIC INTEREST IN DIFFERENT ASSETS OF COMPANY AND IS
ACTIVELY PURSUING OPTIONS
    * MEIRAGTX:SANOFI TO GET RIGHT OF FIRST NEGOTIATION TO USE
RIBOSWITCH GENE REGULATION TECHNOLOGY FOR SOME
IMMUNOLOGY,CENTRAL NERVOUS SYSTEM TARGETS
    * MEIRAGTX HOLDINGS- SANOFI TO GET A ROFN FOR USE OF CO'S
RIBOSWITCH GENE REGULATION TECHNOLOGY FOR GLP-1 AND OTHER GUT
PEPTIDES FOR METABOLIC DISEASE
    * MEIRAGTX HOLDINGS PLC - SANOFI TO RECEIVE ROFN FOR
MEIRAGTX'S
PHASE 2 XEROSTOMIA PROGRAM

Source text for Eikon:  ID:nGNX8C68m6 
Further company coverage:  MGTX.O 

 ((Reuters.Briefs@thomsonreuters.com))